Since 1983, PROGEN has been an established manufacturer and supplier of premium antibodies, in vitro diagnostics, and reagents for the global life science research community. The company’s portfolio attracts and serves a well-diversified clientele in research institutes and universities, pharmaceutical and biotech companies as well as private and clinical laboratories.
While PROGEN antibodies are among the most published antibodies in biomedical and cell biology literature, PROGEN ELISA kits aim at niche markets in microbiology, infectious diseases, and immunology. Products for in vitro diagnosis applications include PROGEN assay kits for infectious disease, coagulation and lipid metabolism. These are complemented by a range of purified and recombinant proteins suitable for use as antigens and controls.
Building on an extensive core-competency and experience in immunochemistry, PROGEN has expanded its product and service portfolio in recent years to include recombinant antibody engineering, antibody phage display technology, density gradient media, and AAV (adeno-associated virus) test kits for gene therapy research. All PROGEN products are backed by a commitment to quality and meet the requirements of the directive 98/79/EC of 27 October 1998 on in vitro diagnostic medical devices.